Drug Information

Drug General Information
Drug ID
D02NZE
Former ID
DIB019554
Drug Name
compound 5m
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530930]
Structure
Download
2D MOL
Formula
C31H33ClF3N5O
InChI
InChI=1S/C31H33ClF3N5O/c32-25-7-8-27(31(33,34)35)24(17-25)20-40-16-11-36-29-28(40)18-23(19-37-29)21-3-5-22(6-4-21)30(41)39-14-9-26(10-15-39)38-12-1-2-13-38/h3-8,17-19,26H,1-2,9-16,20H2,(H,36,37)
InChIKey
JVVGHVJDZJSKRA-UHFFFAOYSA-N
PubChem Compound ID
46871638
PubChem Substance ID
99311257, 103764029, 104142582, 120905933, 137882868, 180416889, 224159572, 227794251, 246123784, 249565886
Target and Pathway
Target(s) BMP2 inducible kinase Target Info Inhibitor [530930]
ALK tyrosine kinase receptor Target Info Inhibitor [530930]
KEGG Pathway Non-small cell lung cancer
WikiPathways Differentiation Pathway
References
Ref 530930Synthesis and structure-activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase. Bioorg Med Chem. 2010 Jun 15;18(12):4351-62.
Ref 530930Synthesis and structure-activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase. Bioorg Med Chem. 2010 Jun 15;18(12):4351-62.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.